IDSA names hospital stewardship standouts
The Infectious Diseases Society of America (IDSA) yesterday awarded its Antimicrobial Stewardship Centers of Excellence designation to 25 US hospitals.
The program, created in 2017, recognizes hospitals that have established stewardship programs that are led by infectious diseases (ID) physicians and ID-trained pharmacists and have achieved standards established by the Centers for Disease Control and Prevention. It places emphasis on a hospital's ability to implement stewardship protocols using its electronic health record system and to provide continuing stewardship education to its medical staff.
"The Centers of Excellence program recognizes institutions that share our commitment by establishing antimicrobial stewardship programs that foster optimal therapies that protect patients from dangerous antimicrobial resistant infections while safeguarding our vulnerable drug supply. IDSA is proud to partner with each of these institutions in turning the tide against antimicrobial resistance," IDSA President Paul Auwaerter, MD, MBA, said in a news release.
Among this year's recipients are Cleveland Clinic (Cleveland), Tufts Medical Center (Boston), Rush University Medical Center (Chicago), Rose Medical Center (Denver), and UCLA Health (Los Angeles).
Aug 6 IDSA news release
Competition seeks innovative AMR solutions for low-resource settings
A new online competition looking for innovative and creative solutions to address antimicrobial resistance (AMR) in low-resource healthcare settings has launched, with the goal of implementing the solutions in various countries around the world.
Innovate4AMR is seeking to engage student teams to design novel strategies that could help current or future healthcare professionals tackle the underuse, overuse, and misuse of antibiotics that occur in many low-resource settings. The proposed solutions should be catered to the existing AMR landscape in a given geographic area, be financially sustainable, and have the potential for real-world adoption and lasting impact.
The competition is sponsored by ReAct—Action on Antibiotic Resistance, the Innovation + Design Enabling Access (IDEA) Initiative at Johns Hopkins Bloomberg School of Public Health, and the International Federation of Medical Students' Associations.
"We hope to engage and enlist the next generation of leaders in developing innovative, scalable approaches to address the challenge of conserving existing antibiotics. Those in the healthcare sector have a particularly crucial role to play in finding new solutions," Anthony So, MD, MPA, director of the ReAct Strategic Policy Program and the IDEA Initiative, said in a press release.
Proposals are due Sep 17, and winners will be announced Oct 5. Finalist teams will attend a capacity building workshop in Geneva during World Antibiotic Awareness Week (Nov 12-18).
Aug 3 Innovate4AMR press release